Nivolumab is a recently approved medication for the treatment of unresectable malignant melanoma. Many immune-related adverse events (irAEs) associated with nivolumab have been reported. such as pneumonitis. hepatitis. https://unitedssports.shop/product-category/sweaters-clothing-junior-tops-hoodies/